Celnovte Biotechnology Inc

Array Star Inc is a Rockville-based company that offers a wide range of services and products related to RNA research and analysis. Their services include microarray analysis, sequencing, real-time qPCR, and mass spectrometry, while their product offerings include research tools and reagents for studying various RNA classes. With a focus on non-coding RNA, epitranscriptomics, and gene expression, Array Star Inc provides comprehensive solutions for researchers in the field of RNA biology. Array Star Inc also offers specialized services such as DRIPc-Seq, ChIP-Seq, and RNA-Seq, enabling researchers to investigate specific aspects of RNA function and regulation. Their array services cover a diverse range of RNA types, including lncRNA, circular RNA, small RNA, and tRNA. With a commitment to providing high-quality data and reliable analysis tools, Array Star Inc supports scientists in advancing their understanding of RNA biology and its implications in various biological processes.Generated from the website

PlantVax is a leading producer of high purity plant derived enzymes, offering a range of commercial sales and research opportunities. With a focus on applied research and production, their portfolio includes enzymes such as AChE, BChE, rAChE, and rBChE, catering to scientific research establishments and esteemed partners like NIH, DTRA, FLIR, and Huckworthy. Through their SBIR and STTR programs, PlantVax continues to innovate and develop new enzyme products, providing valuable solutions for various industries. Discover how PlantVax can assist you in harnessing the power of plant-derived enzymes by reaching out to them today.Generated from the website

Cellphire Therapeutics, based in Rockville, MD, is dedicated to revolutionizing the treatment of hemorrhage by harnessing the unique biology of platelets. With a mission to prevent unnecessary deaths from controllable hemorrhage, the company focuses on developing innovative platelet therapeutics to meet the urgent needs of both military and civilian patients. Currently, Cellphire is advancing its two differentiated products, CLPH-511 and FPH Thrombosomes, through Phase 2 clinical studies, aiming to address critical challenges posed by the limited shelf-life of conventional platelets. The company's vision is to enhance hemostatic efficacy and ensure that life-saving therapies are readily available to clinicians during emergencies. Generated from the website